Sentence examples for difference in trial from inspiring English sources

The striking difference in trial win rates between judge and jury trials continues.

On each repetition, before starting the time-resolved LDA, all trials were randomly divided into two categories with the constraint that each group contained a similar number of photographs and line drawings, and approximately the same amount of animate and inanimate objects (the difference in trial numbers was smaller than 8%).

Another major difference in trial design is the use of open- or double-blinded methodology.

Therefore, there will be 80% power to detect at least a 5.1% absolute difference in trial enrollment rates between patients attending a pediatric centre and those attending a RCC.

δ When analysed as a continuous variable, there was no difference in trial duration for studies that had a mean control group weight loss and those that had a mean control group weight gain.

At 52 weeks, abatacept is expected to result in a higher proportion of responders than placebo and comparable response rates to other biologic agents except for certolizumab pegol (OR:0.51, 95% CrI: 0.26; 0.96) although these results need to be interpreted with caution due to the earlier described difference in trial design.

Even with the effect of same-trial facilitation nulled, the upper graph of Figure 4A shows a difference in trial-over-trial depression of about 5 spikes/s between '1-1' pairs (green trace) and '0-0' pairs (blue trace).

There was no difference in trials between the WKY and SD strains: no significant main effect of strain in trials [F 1,14) = 2.991, p > 0.05], and no significant strains by stages interaction in trials [F 6,84) = 0.298, p > 0.05].

We suggest that it is too early to draw strong conclusions because the two relevant trials cover different populations in different countries and there may be differences in trial conduct and outcome assessment.

The scientific implications of participant recruitment from these diverse geographic regions and of the differences in trial characteristics in different regions warrant further exploration.

There are several reasons for this variability, including differences between BCG substrains, exposure to non-tuberculous mycobacteria (NTMs), the nutritional or genetic background of the population, differences in trial methods and variations between different clinical Mycobacterium tuberculosis strains [ 2- 6].